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Abstract
Background: Since early 2000, intensive policing, wide scale street drug testing, and actions aimed at limiting the
availability of specific drugs have been implemented in Georgia. Supporters of this approach argue that fear of
drug testing and resulting punishment compels drug users to stop using and prevents youth from initiating drug
use. It has been also stated that reduction in the availability of specific drugs should be seen as an indication of the
overall success of counter-drug efforts. The aim of the current review is to describe the drug-related law
enforcement response in Georgia and its impact on illicit drug consumption and drug-related harm.
Method: We reviewed relevant literature that included peer-reviewed scientific articles, stand-alone research
reports, annual drug situation reports, technical reports and program data. This was also supplemented by the
review of relevant legislation and judicial practices for the twelve year period between 2002 and 2014.
Results: Every episode of reduced availability of any “traditional” injection drug was followed by the
discovery/introduction of a new injection preparation. The pattern of drug consumption was normally
driven by users’ attempts to substitute their drug of choice through mixing together available alternative
substances. Chaotic poly-substance use and extensive utilization of home-made injection drugs, prepared
from toxic precursors, became common. Massive random street drug testing had little or no effect on the
prevalence of problem drug use.
Conclusions: Intensive harassment of drug users and exclusive focus on reducing the availability of specific
drugs did not result in reduction of the prevalence of injecting drug use. Repressive response of Georgian
anti-drug authorities relied heavily on consumer sanctions, which led to shifts in drug users’ behavior. In
most cases, these shifts were associated with the introduction and use of new toxic preparations and
subsequent harm to the physical and mental health of drug consumers.
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Background
The need for an evidence-based and balanced approach
to illicit drug consumption has been repeatedly acknowl-
edged in scientific literature and, increasingly, in political
advocacy [1, 2]. With a growing number of jurisdictions
willing to experiment with drug control approaches, the
national and international debates on rational and effect-
ive policy models have been gaining momentum. An
integral part of these debates has been focusing on the
impact of different enforcement measures on illicit drug
markets and patterns of drug use. While in the
developed world there has been a fair amount of
literature accumulated on the issue [3–6], research
investigating this topic in low and low-middle income
countries has been scarce. Current analysis aims to fill
this gap through critical review of supply reduction
interventions and associated changes in patterns of illicit
drug use in the former Soviet Republic - Georgia.
Home of 3.7 million inhabitants, Georgia is situated in
South Caucasus region and borders with Russian
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Federation (north), Azerbaijan and Armenia (east),
Turkey (south) and the Black Sea (west). Following the
fall of Soviet regime in 1991, Georgia went through a
turbulent period of economic transformation and civil
unrest. A perceived rapid increase in illicit substance
use, in particular injection drug use has been attributed
to the relaxation of social fetters and border control, se-
vere economic crisis and reassessment of values [7, 8].
Neither the Georgian system of post-Soviet narcology
(addiction medicine) nor the government were prepared
to meet the challenges posed by escalation of drug use
and associated problems [9]. Despite some moves
towards the introduction of evidence-based health inter-
ventions (introducing methadone treatment in 2005)
priority was given to repressive measures and supply
control [10]. Since the mid-2000s, intensive policing,
wide scale street drug testing, and measures aimed at
limiting availability of specific drugs have been seen by
the government as a solution to the country’s drug prob-
lem [11]. Annually, tens of thousands of people were
detained in the streets and subjected to drug testing
[12]. Positive tests resulted in an administrative fine
(double of average monthly salary), if documented for
the first time, or in criminal sanctions, including one-
year imprisonment, if documented for the second and
subsequent times during 12 months. In addition, popular
campaigns demonising specific drugs, which were the
most popular at the time, and law enforcement interven-
tions targeting illicit supply of those drugs have been
common. Supporters of this approach argued that fear
of drug testing and following punishment compelled
drug users to stop using, and prevented youth from
initiating drug use. It was also stated that reduction in
availability of specific drugs should be seen as an indica-
tion of the overall success of law enforcement measures
[13]. The aim of the current review is to describe the
drug-related law enforcement response in Georgia and
to assess the impact of enforcement-based supply and
demand reduction interventions on illicit drug consump-
tion and drug-related harms.
Methods
For this policy case study, we reviewed relevant literature
that included peer-reviewed scientific articles, stand-alone
research reports, country annual drug situation reports,
technical programmatic reports and programme data. In
addition, we made a detailed review of relevant national
legislation and judicial practice for 2002–2014. The litera-
ture was obtained between March-May 2015 through
searches of a number of databases and online resources.
These included: academic databases (Medline, Scopus,
Google Scholar), and online legal and statistical databases
(Legislative Herald of Georgia, Parliament of Georgia,
National Statistics Office of Georgia, Ministry of Justice of
Georgia, Ministry of Internal Affairs of Georgia). Re-
markable part of information was obtained through
direct written requests to ministries and other govern-
ment institutions (Ministry of Justice of Georgia,
Ministry of Internal Affairs of Georgia, Supreme Court
of Georgia, Office of Prosecutor General of Georgia,
Ministry of Corrections of Georgia, Ministry of
Labour, Health and Social Affairs of Georgia). Docu-
ments included in this review were those containing
information on legislation, policy and framework doc-
uments, and law enforcement and public health statis-
tics related to illicit drug use. Of particular interest
were annual drug situation reports, research reports
and other documents that focused on evidences and
analysis of policy and law enforcement practice, and
patterns of illicit drug use and other behaviours
exercised by people who inject drugs (PWID).
Since there is no drug information system in Georgia
that would make a comprehensive assessment of drug
market changes, we relied on two major sources – results
of two surveys that have been systematically collecting
standardized and comparable data on current injection
drug use (defined here as the last week or last month
injection use). The first was a programme database of
the Georgian Harm Reduction Network (GHRN) - a
non-governmental non-profit organization that runs 14
low threshold programmes in 11 cities and is a single
major provider of harm reduction services to PWID in
Georgia. The Global Fund to Fight AIDS, Tuberculosis
and Malaria (GFATM) has funded these services. Start-
ing from 2007, GHRN has collected data on socio-
demographics and injection practices (including drugs
injected during last month) among current injection
drug users utilizing its services. Respondents for this
annual, brief (16 questions), paper based survey, admin-
istered by social workers at each site, were recruited
based on a convenient sampling among the clients of
needle exchange programmes in all 11 cities. Total
sample size varied from 1,200 to 2,500 depending on a
year of the survey. Data were entered into excel data-
base and results of a descriptive analysis were reported
by GHRN systematically. The second source was a bi-
annual Bio-Behavioural Surveillance Survey (BBSS) that
has been implemented since 2002 in major cities. Fund-
ing for BBSS survey was initially provided by the United
States Agency for International Development (USAID)
and last two waves were funded by GFATM. BBSS has
been implemented by the consortium of public and
private research agencies and has employed standard-
ized methodology for all waves of the survey. This
anonymous, paper-based, interviewer-administered sur-
vey, among other data, has been collecting information
on current use (last week use for 2002, 2004, and 2006,
and last month use for 2008, 2012, and 2014). The
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survey utilized Respondent Driven Sampling approach
and recruited on average 1,600 current injection drug
users for each wave in six largest cities of the country.
BBSS reports, released at the end of each wave,
included results of descriptive and bi- and multi-variate
analysis. For the purpose of current review we summa-
rized the results of descriptive analysis of GHRN and
BBSS surveys. The primary outcomes of interest were
prevalence and patterns of illicit drug use, measured
through indicators of current use of four major injec-
tion drugs: heroin, buprenorphine, home-made ATS,
and home-made opioids (desomorphine).
Our analyses included critical assessment of policy
changes and law enforcement interventions along the
timeline of events, and concurrent changes in patterns
of use. While triangulating the data obtained from a
number of sources, we considered relationships between
enforcement and drug users’ behavior, examined the
adaptations that drug injectors (and/or markets) made




In mid 1990s traditional raw opium was pushed out of
the drug scene by rapid introduction of heroin, which
was later partially replaced by buprenorphine in the
form of Subutex® tablets [7]. Subutex® was reported as
the primary drug of dependence for 40 % of patients
admitted to inpatient treatment in 2005 [14]. About half
of Subutex® injectors reported that they used it as a
substitute for traditional opium or heroin [15]. At about
the same time marked increase in injection use of
home-made amphetamine-type stimulants (ATS) known
as vint and jeff was observed (Fig. 1).
The emergence of home-produced stimulants was
evidently linked to increased mobility and labour
migration to Russia and Ukraine, as well as diffusion of
information, including recipes via internet [16]. By 2009
the prevalence of Subutex® injection use was dramatic-
ally reduced (from 75 % in 2007 to 7 % in 2013 - last
month prevalence among drug injectors) [17]. By that
time poly-substance use became widespread, with some
studies reporting 90 % prevalence of concurrent use of
two or more substances and 75 % prevalence of concur-
rent use of three and more substances among PWID
[15]. Since then concurrent, often-unstructured use of
multiple substances has remained an important charac-
teristic of Georgian drug scene. For example, in 2014 on
top of use of major injection drugs (as seen in Fig. 2)
42 %, 35 %, and 41.4 % of needle and syringe program
(NSP) clients also reported use of alcohol, marijuana
and sedatives respectively (data not shown).
In 2010 we documented first reports on the injection
use of so-called “krokodil” (desomorphine), a home-made
opioid produced from pharmaceutical drugs containing
codeine [16]. By 2012 krokodil was the most frequently
injected drug with 42 % and 36 % of drug injectors
reporting last month use in GHRN and BBSS surveys
respectively [18, 19] – see Figs. 1 and 2. Expectedly
krokodil users composed a significant share of admis-
sions in addiction clinics [20]. Prevalence of krokodil
injection use was reduced from 53 % in 2013 to 34 %
in 2014 (last month prevalence) in a GHRN sample,
and from 36 % in 2012 to 17 % in 2014 in a sample
of BBSS respondents. Both heroin and buprenorphine
showed signs of increase, with the former drug regaining
the status of the most often injected illicit substance for
the first time since 2003 [21, 22].
To provide a full picture of the ever-changing drugs
scene, it is important to mention the abuse of other
products and over-the-counter medications that were
popular for shorter periods of time and/or were charac-
teristic to particular geographic areas of the country.
Fig. 1 Trends in drugs injected in Georgia in 2002–2014 based on BBSS data (percentages exceed 100 % due to multiple responses, depending
on a current poly-substance use by respondents)
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Oral abuse of tramadol in combination with sedatives
was reported in mid 1990s [7]. In 2003 Georgia experi-
enced an explosive abuse of an injection preparation
produced from poppy seeds that were normally used as
an ingredient for different food (confectionery manufac-
turing) [7]. In 2005–2008 injection use of antidepressant
tianeptin (Coaxil®) was widely reported from different
regions, in particular west Georgia [23]. In 2010–2011
widespread oral consumption of anticonvulsant pregaba-
lin (Lyrica®) was observed throughout the country [11].
And finally, in 2014 the first reports on injection use
of eye drops Tropicamide® (benzeneacetamide) were
released. Tropicamide® injections were reportedly used
as a substitute by opioid injectors [17]. Table 1 presents
the timeline and descriptive summary of events in relation
to policy changes, drug use patterns and factors that
contribute to changes in users’ behaviour.
Policy interventions and legal practice
We identified two major events that contributed to the
improved availability of and access to evidence based
treatment for substance use disorders. The first was the
new Law on Narcotic Drugs, Psychotropic Substances,
Precursors and Narcological Aid adopted in 2002 and
which permitted use of substitution treatment with opioid
agonists [24]. The treatment itself was launched in 2005
with the support from the GFATM. The second event was
the decision of the Ministry of Labour, Health and Social
Affairs to allocate funding for opioid substitution treat-
ment and the launch of state co-funded programs in 2008.
State support allowed for rapid expansion of the treat-
ment. By the end of 2013, there were seven-teen treatment
sites in the country that served a total of 4,600 patients
annually [17] – see Fig. 3. Treatment of more than two
thirds of those patients was co-funded by the state.
In relation to enforcement measures we distinguished
three principal elements that were characteristic for
drug-related response in last decade. The first was intro-
duction of stricter measures over the control of specific
substances in response to the increased abuse of these
substances. In most cases this was done through moving
the substance to another (more tightly regulated) list/
schedule of controlled substances. This was done in rela-
tion to tramadol, poppy seeds, buprenorphine, tianeptin,
pregabalin, codeine and few other substances.
Another element of Georgian legal response to drugs
problem was introduction of legislation that would im-
pose additional (to existing) punishment for drug related
offences and/or new restrictions for civil rights of indi-
viduals engaged in illicit drug use. For example the New
Law on Drug Crime adopted in 2007 introduced further
restrictions for individuals sentenced for drug-related
crimes. The law was intended to discourage illicit drug
use via deprivation of driving license, arms license, a ban
on passive election right, a ban on certain professional
activities, (lawyer, physician, teacher and the like) and
other rights [25].
And finally, the critical element of the enforcement was
large-scale street drug testing introduced since 2007. In late
2006 the Georgian government announced a war against
crime, with drugs being one of the highest priorities.
Massive drug testing was launched with a 12-fold increase
in the number of persons tested annually between 2006
and 2007 [12]. The fine for the first time drug use (positive
urine test) increased 5-fold and reached double the amount
of the average monthly salary in the country [26]. Since
then, annually, tens of thousands of people have been tested
for presence of derivates of controlled substances in their
urine (Fig. 4). Following the peak in 2007, the number of
tested individuals was gradually decreasing until the new
peak in 2013. Notably, the proportion of negative versus
positive test results has remained stable – 2:1.
All these efforts were accompanied by wide scale TV
public campaigns - “Killer in the city”, “Anything but
Fig. 2 Trends in injecting drug use in Georgia 2007–2014 based on GHRN data (percentages exceed 100 % due to multiple responses, depending on
a current poly-substance use by respondents)
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Table 1 Timeline of major policy events and changes in drug use patterns
Timeline Legal changes Enforcement measures/practice Drug use patterns Factors influencing users behavior
Mid 1990s • Widespread corruption among police
• Drug users - subjects to harassment
and extortion of bribes
• Opium↓ replaced by heroin↑
• Tramadol + sedatives↑
Late 1990s • Tramadol scheduled
Early 2000s • Heroin↓ replaced by
buprenorphine (Subutex®)↑
• 40 % of treatment clients say
Subutex® is primary drug
• More than half report they use
Subutex® to substitute opium
or heroin
• Home-made ATS (vint, jeff)↑
• Buprenorphine not detected
by police urine testing
• External signs of intoxication
less visible
• Increased mobility to Russia
and Ukraine
• Recipes via internet
2002–2003 • New Frame Law on Narcotics
allowed substitution therapy
• Poppy seeds scheduled
• Poppy seeds↑ • Price/availability
2005–2008 • Tianeptin (Coaxil®)↑
• Home-made ATS↑
• Price/availability
• Not detected in police
urine tests
2005 • Tianeptin scheduled • First OST programme opened (GFATM) • Subutex® and
heroin - leading drugs
2006 • War on crime - war on drugs
• Adm. fine for drug use increased
5 fold
• Drug testing facility moved to MIA
• Massive street drug testing launched
• 12 fold increase in persons tested
in 2007 vs 2006
2007 • New law on Drug Crime (restrictions
on civil rights)
2007–2009 • Subutex-enemy #1
• Public campaigns “Anything but
Subutex”, “Killer in the city”
2008 • First state supported OST opened
2009–2013 • Victory over Subutex® and
heroin announced
• Subutex®↓last month use
from 75 % in 2007 to 7 %
in 2013)
• Heroin↓
• Poly-subs use↑ (90 % of
injectors use 2 or more
drugs, 75 % use 3 or
more drugs)
• Availability (police claimed they
successfully collaborated with
French counterparts to restrict
smuggling of buprenorphine)
2009 • PDU size estimation - 40,000
2010 • Pregabalin scheduled • State funded OST scaled
up - 17 sites
• 4,600 patients treated in 2013
• Testing↓, imprisonment↓
• Pregabalin (Lirica®)↑ • Substitute for injectable opioids
• Not in narcotics list
• Not detected by police tests















Table 1 Timeline of major policy events and changes in drug use patterns (Continued)
• No need to engage with
dealer/illicit market
2011 • Presidential Decree- Interagency
Coordinating Council established
2012 • Krokodil - leading inj. drug
• PDU size estimation - 45,000
2013 • National (anti)Drug. Strategy and
Action Plan 2013–2015
• New Government came to power
• Codeine tablets moved under
strict control
• 60,000 tested• Testing↑,
Imprisonment↑
• Krokodil named as most
dangerous drug
2014 • Law on New Psychoactive Drugs • Victory over krokodil announced
• MIA reported 90 % reduction
in Krok. use (based on seizures
and urine tests)
• MIA reported 90 % reduction in
NPS use (based on seizures
and urine tests)
• Krokodil ↓( from 53 % in 2013
to 34 % in 2014, GHRN)
• Heroin ↑ (heroin driven
commuting to Turkey)
• Buprenorphine ↑
• Tropicamide injection ↑
• Attempts to compensate for
reduced desomorphine














Subutex®”, “Let’s defeat dependence together” – that
supposedly aimed at preventing use of specific drugs
(one per campaign), and focused on horrifying messages
about immediate and inevitable harmful effects of
those drugs (dependence, cancer, psychosis, death and
so on) [11].
In an attempt to establish coordination mechanism for
drug related activities the Inter-Agency Coordinating
Council to Combat Drug Abuse was established by
decree of the President. The Council was mandated to
elaborate and coordinate the implementation of the
national drug strategy and action plan [27]. In 2013 with
the new government in power, the National (anti)Drug
Strategy and Action Plan were developed and approved
by the Interagency Coordinating Council. However, clear
mechanisms of implementation and monitoring have
not been established [17]. In the same year, a new wave
of massive street drug testing was launched with a
record of 60,196 episodes of drug testing performed
(Fig. 4). In contrast, there were 5,269 individuals admit-
ted for treatment (both drug free detoxification and
opioid agonist maintenance treatment) for substance use
related problems in the same year (Fig. 3).
Discussion
The drug control regime in Georgia has been focusing
primarily on law enforcement measures to target supply
and availability of particular drugs and to reduce demand
through imposing harsh punishment on drug users. There
is a lack of evidence available suggesting any positive
Fig. 3 Number of patients treated for substance use disorders in 2003–2013. Fig. 6 in Alavidze, S., Balanchivadze, N., Batselashvili, L., Duchidze, N.,
Javakhishvili, J., Kikvidze, T., . . . Tsertsvadze, V. (2014). Drug Situation in Georgia 2013. In J. Javakhishvili, Otiashvili, D., Tabatadze, M. (Ed.). Tbilisi.
Used with permission
Fig. 4 Number of individuals tested for drugs and number of positive results, 2006–2013. Figure 17 in Alavidze, S., Balanchivadze, N., Batselashvili,
L., Duchidze, N., Javakhishvili, J., Kikvidze, T., . . . Tsertsvadze, V. (2014). Drug Situation in Georgia 2013. In J. Javakhishvili, Otiashvili, D., Tabatadze, M.
(Ed.). Tbilisi. Used with permission
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results in terms of reduction in the prevalence of problem
drug use and/or its negative consequences. Reactive in its
nature, the simplistic, repressive response heavily relied on
consumer sanctions and stimulated shifts in drug markets
and users behavior. In most cases these shifts were associ-
ated with the introduction and use of new toxic prepara-
tions and subsequent harm to the physical and mental
health of individuals.
Old markets limited - new markets explored
Efforts to limit the availability of particular drugs almost
uniformly lead to an increase in use of other drugs,
development of new sources of supply and/or produc-
tion of new substances [28]. The heroin shortage in
Australia in 2000–2001 provided a useful example of
drug market shock in which the abrupt reduction in
supply of heroin, with consequent increase in its price
and decrease in purity and availability, resulted in a clear
reduction in heroin use and increase in use of other
drugs. The majority of heroin users reported a compen-
satory increase in consumption of cocaine, cannabis,
benzodiazepines and methamphetamines [3, 29–31]. An-
other example was the spread of small-scale manufacturing
of methamphetamine-like preparations utilizing over the
counter cold medications and other more easily obtained
chemicals, in response to the US government’s attempt to
halt the illegal manufacturing of methamphetamine by
regulating the sale and distribution of the precursor chemi-
cals in the 1980’s. As stated by Cunningham and Liu, “the
end result was an explosion in rural manufacturing and
dangerous explosions of small kitchen labs used by meth
addicts to cook up their own supplies of speed” [32].
Where illicit drug markets and distribution schemes
are concerned, both traditional and novel control
measures have been met with rapid countermeasures
and technological innovations [33–35]. Recently, the
rapid increase in use of new psychoactive sub-
stances (NPS) has brought a global change in drug
markets, with the number of NPS already exceeding
the number of psychoactive substances controlled at
the international level [36, 37]. More than this, the
Internet has shown to make an impact on the drug
markets dramatically and has allowed information on
drug use and production to spread rapidly, effectively fa-
cilitating the diffusion of new trends [6, 38].
Consistent with these findings, our research suggests
that Georgian drug markets and drug users have shown
a considerable capacity and innovation to adapt to new
regulatory measures and increased scrutiny by law en-
forcement. Reduction in availability of traditional drugs
led to the exploration and rapid growth in use of new
drugs, mostly domestically manufactured substances.
Describing and understanding organized drug distribu-
tion networks falls beyond the scope of this report.
However, available data might suggest that these net-
works have been remarkably overshadowed by the rapid
emergence of freelance distribution of Subutex® in mid-
2000s (smuggling from Europe by leisure or business
travellers [14]), as well as by user-driven kitchen produc-
tion of injection preparations. It is to be investigated to
what extent the Internet (for example, online recipes for
self-production) has been influencing the development
of Georgian drug markets.
This policy review provides unique example of a small
country in which multiple specific policy interventions
resulted in prompt and dramatic changes in drug con-
sumption patterns. The scale and dynamics of these
changes were impressive. Within 1–2 years, introduction
and spread of new injection drugs/preparations, and a
similarly rapid decline in consumption of these prepara-
tions evidently in response to targeted enforcement
measures, only to give way to new substances. As argued
in the following sections, the ultimate result of these
changes did not seem to have led to any improvement in
individual or public health. Rather, vice versa. Drug users
switched to more toxic preparations and exercised more
risky behaviour. However, the sensitivity and responsive-
ness of market players, seemingly very effective and
rapid diffusion of information and new trends in the
Georgian drug user setting can, and should, provide a
window of opportunity (and become a focus of future
research endeavours) for innovative approaches to educate
and support behavioural changes aiming at reduction of
negative consequences of substance use.
Drivers behind changes in patterns of drug consumption
Development in substance use patterns is driven by a
complex set of factors and socio-economic context. In
many cases, drug use patterns in Georgia were largely
shaped by policy response and law enforcement prac-
tices implemented at particular periods of time. Among
others, these changes were driven by both consumers’
attempts to substitute the traditional drug of their choice
and to make drug use less visible, so that risk of arrest
would be reduced. In our previous report we suggested
that less visible external signs of intoxication and ab-
sence of buprenorphine in the police drug testing kits
played an important role in the rapid spread of Subutex®
consumption in mid-2000s [15]. This lack of detectabil-
ity obviously contributed to the spread of home-made
ATS injection as well. As in case with buprenorphine,
standard urine testing kits used by police did not include
amphetamine and methamphetamine (at least at the
initial stages), thus allowing users of vint and jeff to pass
testing undetected. The same goes for other experimental
drugs like Coaxil®, Lyrica®, and Tropicamid®. In addition,
the risk of arrest was reduced since all the ingredients for
kitchen production were obtained via pharmacy and
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convenience stores and there was no need to engage with
drug dealers. Importantly, new injection preparations were
remarkably cheaper - $5-7 per single dose of vint, jeff or
krokodil, compared to $50-100 per single dose of heroin
or buprenorphine.
Apart from directly influencing the supply of illicit
drugs, law enforcement seeks to reduce the demand by
making drugs expensive, hard to obtain and/or too risky
to engage with. In Georgia politicians have argued that
law enforcement (massive drug testing) reduces the
demand by increasing the probability to get punished
and thus coerces drug users to stop using drugs. In
reality, the risk of detection is fairly limited and the
improvement of detection rates is unrealistically expen-
sive [28]. In the United States, cannabis users had a tiny
1 in 3,000 risk of being arrested for any given incident of
cannabis use [4]. Simple calculations (45,000 problem
injection users; roughly one injection per day; 20,000
positive results of the rapid urine toxicological testing in
2013 – see Fig. 4) give us about 1 in 1,000 risk of being
arrested for any given incidence of injection drug use in
Georgia. To be more accurate, this risk is even lower
since 20,000 positive test results include non-injection/
non-problem drug use as well, mainly marijuana. Obvi-
ously, this risk is low enough to support the assumption
that it should drive the drug user’s decision to stop
using. However low the risks of detection and arrest
may be, it seems that Georgian drug consumers still did
not ignore those risks. We believe that severe and
grossly disproportionate punishments for possession/use
of illicit substances involving long-term incarceration
were important contributors to that. For example, pos-
session of heroin in the amount of more than 1 gram,
regardless of the purpose, is punished with 8 to 20 years
of imprisonment or lifetime term (Art. 260 of the Penal
Code of Georgia (III)). According to the same code, rape
is punished with 4–6 years of imprisonment (Art. 137 of
the Penal Code of Georgia) and murder is punished with
7–15 years in prison (Article 108 of the Penal Code of
Georgia) [39]. Such harsh measures combined with large
and frequent police engagement with drug users dramat-
ically reduced the public visibility of people “under the
influence” of psychoactive substances, driving drug users
further underground and making their engagement with
prevention and treatment services extremely difficult.
New drugs – new harms
In an Australian study that described an increase in
consumption of cocaine and other stimulants as a
response to heroin shortage, Topp and co-authors
suggested that “given the differential harms associated
with the use of stimulants and opiates, this possibility
has grave implications for Australia, where the inter-
vention and treatment system is designed primarily to
accommodate opiate use and dependence” [29]. On a
positive note, reduction in overdose deaths and a possible
reduction in injection drug use and hepatitis C infections
were suggested to be potential public health benefits as a
result of the Australian heroin shortage [3]. Switching to
new drugs in Georgia was in many cases associated with
increased risks for blood-borne infections and other
harms often related to the toxic nature of ingredients used
for preparation of self-manufactured injection solutions.
Buprenorphine, home-made stimulants and home-made
opioids all were obtained, processed and used in a way
that required a group of injectors to collaborate. This was
related to either collection of money for expensive 8 mg
buprenorphine tablet, to be later divided and injected by,
usually, four individuals, or to predetermined division of
functions/labor (money, procurement of precursors, cook-
ing) among group members in case of preparation of
home-made stimulants and opioids [11]. In all these in-
stances injection happened within a group of 3–5 drug in-
jectors with apparently little direct sharing, but frequent
indirect sharing via common container, cotton filters, and
large volume syringe for division (front or back loading) of
the produced substance [9, 40].
Addiction clinics and harm reduction programs re-
ported numerous physical, neurological and psychiatric
complications among consumers of home-made prepa-
rations, both stimulants and opioids, which were appar-
ently linked to the toxicity of precursors used for
processing – phosphorus, iodine, potassium permangan-
ate, gasoline, strong acids and so on [41]. Soft tissue
damages, necrosis, gangrene, osteomalacia and other
severe impairments have been reported elsewhere in
connection to injection use of krokodil and self-produced
ATS [42–44]. Harm reduction services in Georgia have
also reported increased demand for naloxone among kro-
kodil injectors. Elevated risk of overdose was apparently
associated with difficulties in titration and fluctuating
quality/potency of self-manufactured krokodil [11].
Attempts to self-medicate and substitute traditional
drugs of abuse have resulted in majority of drug injectors
switching to unstructured poly-substance use. Dependent
drug users consumed whatever intoxicants were available
at the moment, often in combination, aiming to mimic
their drug of choice and/or to increase the potency and
prolong effects. Nine out of ten respondents in one survey
(clients of needle and syringe exchange programmes)
reported injecting at least two drugs, and two-thirds
reported injecting three or more drugs during the last
month [15]. This has apparently resulted in the rise in the
number of overdose since most overdoses occur among
individuals who consume multiple substances [45].
However, overdose cases are not properly documented
in Georgia and we are lacking the data to support
this assumption.
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Legal and ethical aspects of massive street drug testing
In Georgia, tens of thousands of people are subject to
administrative and criminal proceedings (including sen-
tencing to prison terms) as a consequence of positive
rapid immunoassay test results. To the best of our
knowledge, no other jurisdiction uses the results of rapid
screening as irrecusably final evidence of drug use be-
cause of the issues related to the often-low specificity of
the tests, cross-reactivity, and the stability of these
devices (their ability to resist certain conditions, such as
temperature and humidity). Elsewhere, these results are
considered preliminary and indicative, and advanced
confirmatory laboratory tests are required for legal
proceedings both in criminal justice and workplace
settings [46–49]. In Georgia, the results of these rapid
tests are used as one single source of evidence in court,
leading to heavy fines or imprisonment. We believe that
this practice contradicts established international stan-
dards for a fair trial where sufficient evidence should be
required for conviction beyond reasonable doubt of
proof [50]. However, it is obvious that confirmatory
testing of those who tested positive using initial on-site
tests would increase the cost and expenditures of the
testing intervention immensely.
We estimated that 1 in 20 men residing in the country
was tested for drugs in 2013 (60,000 testing episodes
among 1.4 mil men aged 15–64 [51] leaving in Georgia).
Punitive measures, including massive street drug testing,
that have no analogue in developed countries did not
result in any measurable reduction in drug use in
Georgia. Instead, such measures caused the harmful
criminalization of thousands of otherwise law-abiding
individuals. Importantly, these punitive measures had
little or no influence on individual decisions to cease or
to continue using drugs. Our earlier report showed that
89 % of individuals punished for drug use (as per
positive drug test) returned to drugs immediately after
the punishment, and 11 % did so within few months
following the penalty [12]. Punishment did result in a
change in user behaviour – study participants reported
adapting variety of strategies to avoid being identified by
police (injecting alone, injecting and staying at home,
avoiding traveling by taxi and so on).
Finally, it is reasonable to state that massive drug
testing, with the majority of the test results being
negative, raises an ethical question. Subjecting tens of
thousands of people to humiliating and lengthy drug-
testing procedure infringes upon the dignity of citizens
and undermines the public perception of a just and
sound policy. Figure 5 presents a schematic description
of drug policy interventions and relevant health and
social implications in Georgia.
Limitations
As with any research, our review has limitations.
Literature review
In our analysis we focused on associations between
specific law enforcement interventions and changes in
illicit drug markets and substance use patterns. However,
shifts in drug trends are obviously not only a function of
enforcement. Drug markets are responsive to different
Fig. 5 Policy interventions, evolving drug scene and implications
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political, socio-economic and cultural forces. Nevertheless,
analysing those factors, whatever the importance, was
beyond the scope of current review. Secondly, due to lack
or complete absence of data, we were unable to assess the
effect of drug enforcement measures on initiation of drug
use by new users.
Secondary analysis of drug use data
We believe that the reliability of drug use data analysed
for this report was satisfactory. Differences in the preva-
lence of current use of specific drugs in two samples
might suggest that these were somehow different drug
using populations with distinct characteristics and behav-
iours. It is hard to estimate to what extend samples for
two surveys overlap. Between 3.5 % (in Tbilisi) and 44 %
(in Gori) of BBSS respondents reported receiving services
from needle-syringe programs. Importantly, both surveys
reported very similar trends in injection drug use over the
years, which might suggest that these data correctly reflect
availability and/or preferability of particular injection
drugs by significant portion of Georgian PWID at specific
periods of time.
Our general concerns relate to the overall fragmented
character and limited scope of the data available in the
country. Absence of comprehensive drug monitoring
system in Georgia that would provide valid, relevant and
continuous data was the major limitation. In order to
measure changes in drug consumption, we focused on
four major injection substances and relied on data pro-
vided by GHRN annual client survey and periodic BBSS.
Supposedly, both surveys deal with problematic drug
users, whom of which do not necessarily represent the
entire substance-using population in the country. These
problematic poly-substance users can respond to changes
in a specific way, simply saying – consume whatever is
available and rapidly switch to new drugs. Other groups
(recreational, experimental users) may have responded
differently to the changes in the legal environment, but
there are no data to explore that. For example, as is the
case with other countries [36], it is possible that new
psychoactive substances, in fact, attracted new cohorts of
users and they exercised responses and behaviours differ-
ent from those of systematic injection users of drugs.
Again, given the data available, we were unable to examine
trends in NPS consumption and intentionally focused on
four most prevalent injection drugs. Furthermore, since
treatment options in Georgia are fairly limited and
often subject to patient’s ability to cover the cost of
the service, it was hard to measure whether reduction
in supply/availability of specific drugs correlated with
increased utilization of treatment. This is particularly
true for prohibitively expensive drug free treatment
and, to a lesser extent, to more affordable opioid
substitution treatment. It is hard to suggest whether
the visible increase in treatment episodes was a
function of raising demand, or if it only reflected the
persistently unsatisfied high demand for substance use
treatment in the context of inadequate (maximum
10 %) coverage.
Finally, due to the lack of data, we did not discuss the
price and purity of illicit drugs and did not cover the
numbers of negative health and social consequences,
including overdose death, morbidity due to toxic nature
of home-produced injection preparations, criminal justice
costs, social marginalization of users and their families.
Some economic implications of massive street drug testing
were reported earlier [12].
Conclusions
This study highlights the need to re-examine national
drug policy in Georgia. Intensive harassment of drug users
and exclusive focus on reducing availability of specific
drug(s), with no adequate emphases on health interven-
tions, resulted in drug injectors in Georgia exploring new
substances and switching to unstructured poly-substance
use. The toxicity of new alternatives (home-made injection
preparations), chaotic nature of mixing different sub-
stances, and the group character of consumption could be
associated with a number of negative consequences and
increased individual and public health risks.
Development in the drug scene and correlating drug
markets is a dynamic process that requires thoughtful
monitoring. Continuous documentation and analysis of
policy interventions and subsequent changes in patterns
of drug use and associated consequences is warranted in
order to inform decision makers and allow for the
formulation of rationale and effective policy responses.
There is a need to establish a comprehensive drug moni-
toring system in Georgia that would provide professional
community and policy makers with reliable, valid and
systematic data on drug markets and drug use trends
and patterns.
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